Other

Less than 12 months

Humana Less than 12 months increased by 212.7% to $7.29B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 30.3%, from $5.59B to $7.29B. Over 3 years (FY 2022 to FY 2025), Less than 12 months shows a downward trend with a -19.2% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_debt_securities_available_for_sale_continuous_unre_4cdf47

Historical Data

13 periods
 Q4 '22Q1 '23Q2 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$4.42B$3.68B$4.99B$3.62B$4.70B$4.34B$1.55B$7.20B$5.59B$4.62B$2.99B$2.33B$7.29B
QoQ Change-16.7%+35.6%-27.4%+29.9%-7.7%-64.3%+364.7%-22.3%-17.5%-35.3%-22.0%+212.7%
YoY Change-18.1%+27.8%-13.0%+98.8%+18.9%+6.4%+92.9%-67.6%+30.3%
Range$1.55B$7.29B
CAGR+18.2%
Avg YoY Growth+19.6%
Median YoY Growth+18.9%

Less than 12 months at Other Companies

Frequently Asked Questions

What is Humana's less than 12 months?
Humana (HUM) reported less than 12 months of $7.29B in Q1 2026.
How has Humana's less than 12 months changed year-over-year?
Humana's less than 12 months increased by 30.3% year-over-year, from $5.59B to $7.29B.
What is the long-term trend for Humana's less than 12 months?
Over 3 years (2022 to 2025), Humana's less than 12 months has grown at a -19.2% compound annual growth rate (CAGR), from $4.42B to $2.33B.